[
  {
    "ts": null,
    "headline": "Johnson & Johnson stock underperforms Wednesday when compared to competitors",
    "summary": "Johnson & Johnson stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=3bd8167bc2241bada4e319a0450896216e2ca4f4690fd6b8d98be34376326064",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733934660,
      "headline": "Johnson & Johnson stock underperforms Wednesday when compared to competitors",
      "id": 131933285,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=3bd8167bc2241bada4e319a0450896216e2ca4f4690fd6b8d98be34376326064"
    }
  },
  {
    "ts": null,
    "headline": "Pioneer Disciplined Value Fund Q3 2024 Performance And Market Commentary",
    "summary": "Pioneer Disciplined Value focuses on mispriced quality, sustainable US large-cap companies trading at attractive valuations with the goal of maximizing risk-adjusted returns.",
    "url": "https://finnhub.io/api/news?id=d4f3261fd93e6b78ad690012a471451ef57fa7e1bbef1712c590cb1c6e72d1b3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733920800,
      "headline": "Pioneer Disciplined Value Fund Q3 2024 Performance And Market Commentary",
      "id": 131921068,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2152882467/image_2152882467.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Pioneer Disciplined Value focuses on mispriced quality, sustainable US large-cap companies trading at attractive valuations with the goal of maximizing risk-adjusted returns.",
      "url": "https://finnhub.io/api/news?id=d4f3261fd93e6b78ad690012a471451ef57fa7e1bbef1712c590cb1c6e72d1b3"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson reinstated with a Neutral at BofA",
    "summary": "BofA reinstated coverage of Johnson & Johnson with a Neutral rating and $166 price target The current valuation at a premium to other drug names “seems likely to cap upside,” the analyst tells investors while reinstating coverage of 11 large-cap U.S. pharma and biotech stocks. J&J has a “fairly interesting pipeline” and talc litigation resolution in 2025 “would help,” the analyst added. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>",
    "url": "https://finnhub.io/api/news?id=fe12fea4c9169514f1504a2212862b097d6bef07c40239825f90ea4b1b1c37f0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733919345,
      "headline": "Johnson & Johnson reinstated with a Neutral at BofA",
      "id": 131923798,
      "image": "https://media.zenfs.com/en/tipranks_452/6e60166f16c98d232e4fe2b08fd8a093",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "BofA reinstated coverage of Johnson & Johnson with a Neutral rating and $166 price target The current valuation at a premium to other drug names “seems likely to cap upside,” the analyst tells investors while reinstating coverage of 11 large-cap U.S. pharma and biotech stocks. J&J has a “fairly interesting pipeline” and talc litigation resolution in 2025 “would help,” the analyst added. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>",
      "url": "https://finnhub.io/api/news?id=fe12fea4c9169514f1504a2212862b097d6bef07c40239825f90ea4b1b1c37f0"
    }
  },
  {
    "ts": null,
    "headline": "ASH 2024: J&J’s Tecvayli shows promise in transplant-eligible NDMM patient",
    "summary": "GlobalData’s patient-based forecast predicts Tecvayli will reach a peak of $2.1bn in sales globally by 2030 in MM.",
    "url": "https://finnhub.io/api/news?id=40dea016fa24127bb7598556a03ba3d552075625f9a6807012622c97de0e49d9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733913698,
      "headline": "ASH 2024: J&J’s Tecvayli shows promise in transplant-eligible NDMM patient",
      "id": 131917531,
      "image": "https://live-b2b-gdm-figaro1.pantheonsite.io/wp-content/uploads/sites/24/2024/12/shutterstock_2128491041.jpg",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "GlobalData’s patient-based forecast predicts Tecvayli will reach a peak of $2.1bn in sales globally by 2030 in MM.",
      "url": "https://finnhub.io/api/news?id=40dea016fa24127bb7598556a03ba3d552075625f9a6807012622c97de0e49d9"
    }
  },
  {
    "ts": null,
    "headline": "Why Is Johnson & Johnson (JNJ) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?",
    "summary": "We recently compiled a list of the 11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other cosmetic surgery and aesthetics stocks. In the face of economic uncertainty, consumer preferences in the beauty industry are […]",
    "url": "https://finnhub.io/api/news?id=4fe7551f85ade9226c955490d07005264d8e8d2489cc6c07aa49b1b562214ffa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733890842,
      "headline": "Why Is Johnson & Johnson (JNJ) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?",
      "id": 131917532,
      "image": "https://s.yimg.com/ny/api/res/1.2/DBFyZ0OZ_JyFkP8R8eQoiQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/f9ccf3c88c7274582ef19e20143427c2",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other cosmetic surgery and aesthetics stocks. In the face of economic uncertainty, consumer preferences in the beauty industry are […]",
      "url": "https://finnhub.io/api/news?id=4fe7551f85ade9226c955490d07005264d8e8d2489cc6c07aa49b1b562214ffa"
    }
  }
]